IFB AdipositasErkrankungen, Forschungsbereich Bariatrische Chirurgie, Universitätsklinikum Leipzig, 04103 Leipzig, Germany.
Nutrition. 2012 Apr;28(4):378-83. doi: 10.1016/j.nut.2011.07.019. Epub 2012 Feb 2.
Obesity in transplant recipients is a frequent phenomenon but data from body composition analyses in long-term survivors are limited. Body composition and energy metabolism were studied in patients after liver (LTX) and kidney (KTX) transplantation and patients with liver cirrhosis (LCI) or on chronic hemodialysis (HD) and compared to healthy controls.
In 42 patients 50.0 mo (median; range 17.1-100.6) after LTX and 30 patients 93.0 mo (31.2-180.1) after KTX as wells as in LCI (n = 39) or HD (n = 10) patients mid-arm muscle and fat area, body cell mass, and phase angle (bioimpedance analysis), and resting energy expenditure (indirect calorimetry, REE(CALO)) were measured.
Obesity was more prevalent in LTX (17%) than LCI (3%) and in KTX (27%) than in HD (10%). In LTX and KTX, phase angle was higher than in end-stage disease (LTX 5.6° [4.1-7.2] versus LCI 4.4° [2.9-7.3], P < 0.001; KTX 5.9° [4.4-8.7] versus HD 4.3° [2.9-6.8]) but was lower in all patient groups than in controls (7.1°; 4.6-8.9; P < 0.001). In LCI and HD REE(CALO) was higher than predicted, while in LTX and KTX REE(CALO) was not different from predicted REE.
Despite excellent graft function, many long-term LTX or KTX survivors exhibit a phenotype of sarcopenic obesity with increased fat but low muscle mass. This abnormal body composition is observed despite normalization of the hypermetabolism found in chronic disease and cannot be explained by overeating. The role of appropriate nutrition and physiotherapy after transplantation merits further investigation.
肥胖在移植受者中是一种常见现象,但长期存活者的身体成分分析数据有限。本研究旨在研究肝移植(LTX)和肾移植(KTX)后患者、肝硬化(LCI)或慢性血液透析(HD)患者的身体成分和能量代谢,并与健康对照组进行比较。
本研究纳入了 42 名 LTX 后 50.0 个月(中位数;范围 17.1-100.6)和 30 名 KTX 后 93.0 个月(31.2-180.1)的患者、39 名 LCI 患者和 10 名 HD 患者,采用生物电阻抗分析测量了上臂肌区和脂肪区、细胞内液量、相位角(PA),并通过间接测热法(REE(CALO))测量了静息能量消耗。
LTX 患者的肥胖发生率(17%)高于 LCI 患者(3%),KTX 患者(27%)高于 HD 患者(10%)。与终末期疾病患者相比,LTX 和 KTX 的 PA 更高(LTX:5.6°[4.1-7.2] vs. LCI:4.4°[2.9-7.3],P<0.001;KTX:5.9°[4.4-8.7] vs. HD:4.3°[2.9-6.8]),但低于对照组(7.1°;4.6-8.9;P<0.001)。LCI 和 HD 患者的 REE(CALO)高于预测值,而 LTX 和 KTX 患者的 REE(CALO)与预测 REE 无差异。
尽管移植物功能良好,但许多 LTX 或 KTX 长期存活者表现出肌肉减少性肥胖的表型,脂肪增加但肌肉量低。这种异常的身体成分在慢性疾病中发现的代谢亢进正常化后仍然存在,不能用暴饮暴食来解释。移植后适当的营养和物理治疗的作用值得进一步研究。